The Advisory Committee on Immunization Practices (ACIP) that makes recommendations to the Centers for Disease Control and ...
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...
Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...
Dynavax Technologies Corporation ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued a statement underscoring ...
In Southwestern Idaho a regional medical board agreed to prohibit public health clinics in that six-county region from distributing the coronavirus vaccine ... Submit a letter to the editor ...
An effective mRNA vaccine would save taxpayers millions, eliminating the need for the current unpopular bison management policy. Dear Texas A&M Researchers: Although Brucellosis (Bab) has been ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The CDC has recommended that the COVID shot be part of the recommended immunization schedule since 2022, but that recommendation is not a requirement. State governments set vaccination requirements.
Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.